Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome

Purpose: This study aimed to evaluate the efficacy of sivelestat sodium on mortality, oxygenation index, and serum markers in patients with acute respiratory distress syndrome (ARDS) associated with Coronavirus Disease 2019 (COVID-19). Methods: A retrospective analysis was conducted on adult inpatie...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Xiao Che, Wei Hu, Ziying Zhang, Lexiao Wang, Zhe Xu, Fusheng Wang
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	sivelestat sodium mortality rate COVID-19 ARDS
Online Access:	https://www.mdpi.com/1424-8247/17/3/368

Similar Items

Effect of sivelestat sodium on the incidence of ventilator-associated pneumonia in patients with sepsis and ARDS
by: Xingcheng Zhang, et al.
Published: (2025-08-01)

Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of ALI/ARDS patients with COVID-19
by: Ruiying Wang, et al.
Published: (2024-09-01)

A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome
by: Jian Xu, et al.
Published: (2024-06-01)

Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis-Induced Acute Respiratory Distress Syndrome
by: Wu T, et al.
Published: (2025-03-01)

Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study
by: Takahiro Kato, et al.
Published: (2025-08-01)

Sivelestat for septic patients with acute respiratory distress syndrome: a systematic review and meta-analysis of a deadly duo
by: Wen-He Zheng, et al.
Published: (2025-10-01)

Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
by: Qiongli Ding, et al.
Published: (2022-08-01)

The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy
by: Hui Lv, et al.
Published: (2024-06-01)

Suppressive effects of the neutrophil elastase inhibitor sivelestat sodium hydrate on interleukin-1β production in lipopolysaccharide-stimulated porcine whole blood
by: Yasuyoshi Kurimoto, et al.
Published: (2020-02-01)

Effect of Sivelestat in the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
by: Qiongli Ding, et al.
Published: (2023-06-01)

Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study
by: Yuting Li, et al.
Published: (2025-01-01)

The In Vitro Inhibitory Effect of Sivelestat on Elastase Induced Collagen and Metallopeptidase Expression in Equine Endometrium
by: Ana Amaral, et al.
Published: (2020-05-01)

The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-01-01)

Sivelestat in Patients at a High Risk of Postoperative Acute Lung Injury After Scheduled Cardiac Surgery: A Prospective Cohort Study
by: Tang YX, et al.
Published: (2024-02-01)

Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways
by: Hong Zhang, et al.
Published: (2023-05-01)

Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-03-01)

Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification and Mechanistic Exploration
by: Deng X, et al.
Published: (2025-05-01)

Effect and safety of sivelestat on acute severe pancreatitis with systemic inflammatory response syndrome: a retrospective study
by: Jiafeng Xie, et al.
Published: (2025-01-01)

A neutrophil elastase inhibitor, sivelestat, attenuates sepsis-induced acute kidney injury by inhibiting oxidative stress
by: Wei Zhu, et al.
Published: (2024-04-01)

DNase I and Sivelestat Ameliorate Experimental Hindlimb Ischemia-Reperfusion Injury by Eliminating Neutrophil Extracellular Traps
by: Wang CL, et al.
Published: (2023-02-01)

Sivelestat-Loaded Neutrophil-Membrane-Coated Antioxidative Nanoparticles for Targeted Endothelial Protection in Sepsis
by: Juexian Wei, et al.
Published: (2025-06-01)

Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat
by: Changtao Zheng, et al.
Published: (2025-09-01)

Sivelestat Inhibits Vascular Endothelial Injury Induced by Inflammatory Response and Improves the Prognosis of Hemorrhagic Fever with Renal Syndrome in Children: An Ambispective Cohort Study
by: Yi W, et al.
Published: (2024-06-01)

Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
by: Jungbum Kim, et al.
Published: (2025-02-01)

Efficacy of sivelestat in alleviating postoperative pulmonary injury in patients with acute aortic dissection undergoing total arch replacement: a retrospective cohort study
by: Zhiyan Mai, et al.
Published: (2025-02-01)

Prognostic value of the systemic immune-inflammation index in patients with acute respiratory distress syndrome: A retrospective study
by: xiaodong pan, et al.
Published: (2024-02-01)

Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019
by: Sylvia Ranjeva, et al.
Published: (2021-04-01)

Evaluation of the Effects of Baricitinib and Ruxolitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Meta-Analysis Study
by: Mehdi Nurmohammad Ahari, et al.
Published: (2025-04-01)

Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study
by: Yongzhen Fan, et al.
Published: (2020-11-01)

Incidence of noninvasive ventilation failure and mortality in patients with acute respiratory distress syndrome: a systematic review and proportion meta-analysis
by: Jie Wang, et al.
Published: (2024-01-01)

Early Tracheostomy in Trauma Patients with Acute Respiratory Distress Syndrome due to Novel Coronavirus Disease 2019 (COVID-19)
by: Fariborz Ghaffarpasand, et al.
Published: (2020-07-01)

Targeting neutrophil elastase is a promising direction for future cancer treatment
by: Wangqiang Jia, et al.
Published: (2024-05-01)

Relationship between VEGF to PEDF ratio and in-hospital mortality in acute respiratory distress syndrome patients
by: Qifeng Luo, et al.
Published: (2025-01-01)

Plasma renin as a novel prognostic biomarker of sepsis-associated acute respiratory distress syndrome
by: Anjali Chakradhar, et al.
Published: (2024-03-01)

Roles of oral anticoagulant use on the risk of 28-day mortality and in-hospital mortality in patients with acute respiratory distress syndrome
by: Jiayang Huang, et al.
Published: (2025-05-01)

DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome
by: Martina Bradic, et al.
Published: (2022-11-01)

Prognostic Factors of Outcome in Children with Acute Respiratory Distress Syndrome
by: Mohsen Reisi, et al.
Published: (2017-04-01)

The Association Between Etiologies and Mortality in Acute Respiratory Distress Syndrome: A Multicenter Observational Cohort Study
by: Yan Wang, et al.
Published: (2021-10-01)

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
by: Mario Menk, et al.
Published: (2017-08-01)

Short-term Survival of Acute Respiratory Distress Syndrome Patients at a Single Tertiary Referral Centre in Indonesia
by: Zulkifli Amin, et al.
Published: (2017-02-01)